Nourish Secures $100 Million to Enhance GLP-1 Treatment Outcomes

Published on May 19, 2026

Nourish, a startup specializing in nutrition counseling, has become a significant player in the health-tech landscape. With a focus on dietary adjustments, it aims to support individuals who are undergoing GLP-1 treatment, a popular class of weight-loss medications.

As obesity-related health concerns rise, Nourish’s initiatives may help bridge the gap between medication and lifestyle changes. The startup’s approach could redefine how patients engage with their weight-loss journeys, providing them with essential tools and support.

The potential impact of this investment is significant. nutritional counseling, Nourish aims not only to improve individual outcomes but also to contribute to a broader shift in how chronic conditions related to obesity are managed.

Related News